ESMO already has five highly respected and successful journals covering the broad range of research in oncology. However, the Society has identified the need for a new Society-owned journal focussing on research in rare cancers. The Journal will be a gold open access journal and published by Elsevier.
The Editor-in-Chief will be expected to manage the peer review process for submitted manuscripts, appoint and lead an editorial team, working directly with ESMO and other partner societies, and determine the editorial policies of the journal in partnership with ESMO and the journal’s publisher.
Applicants may be based anywhere in the world. Specialists working in any area of oncology or cancer research are welcome to apply, but knowledge of and experience in rare cancers is expected. Applicants should have an MD and PhD (or similar degree), be an ESMO member, and should be able to demonstrate their impact in the field. The ideal candidate will have a proven commitment to education and academic excellence. Editorial support will be provided, as well as an annual honorarium. The term of office will be 5 years in the first instance, with the possibility of renewal once. The editor will be expected to spend approximately 10 hours per week working on the journal, plus participate in occasional meetings. A more complete job description is available on request.
Applications including a CV of maximum 3 pages including details of any positions held with other journals, publication metrics (including h-index and number of citations) and appendix with details of 10 most important publications, short biography (not more than 600 words) and motivation letter of maximum 5 pages outlining your editorial policy and vision for the journal, should be sent by email only to the attention of Prof. Andrés Cervantes at executivesecretariat@esmo.org by 20 May 2024.